Atakan Demir

7PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionClinical midwiferyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 13, 2021
Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study.

Ahmet Bilici, Mukremin Uysal, Serkan Menekse

|Dec 03, 2021
Identifying Knowledge and Practices regarding Cancer Patient Malnutrition: A Survey Study among Oncologists.

Ozlem Sonmez, Evrim Tezcanli, Dilsat Bas

|May 20, 2021
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.

Aykut Bahçeci, Semra Paydaş, Naziye Ak

|Feb 04, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin

|Sep 01, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).

Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç

|Jan 24, 2020
Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Atakan Demir, Nil Molinas Mandel, Semra Paydas

Pageof 2

Frequent Collaborators

4 joint publications

Semra Paydas

3 joint publications

Atike Gökçen Demiray

3 joint publications

Havva Yeşil Çınkır

3 joint publications

Sadettin Kılıçkap